Lam, Mike

Mike Lam

Associate

mike.lam@lw.com
    Lam, Mike

    Mike Lam

    Associate

    mike.lam@lw.com

    Profile

    Mike Lam represents high-growth companies, investment banks, private equity sponsors, and institutional investors in complex capital markets, mergers and acquisitions (M&A), and strategic corporate transactions.

    Drawing on his experience as former in-house corporate counsel at NVIDIA, a full-stack computing and artificial intelligence infrastructure company, Mike brings a practical, business-oriented approach to advising clients navigating pivotal growth stages, particularly in the technology, artificial intelligence, software, and digital infrastructure sectors. He has experience executing public and private M&A, including cross-border transactions for large-cap public companies and private equity sponsors, as well as guiding domestic and foreign private issuers through complex US Securities and Exchange Commission reporting and corporate governance matters. 

    Mike also leverages extensive experience driving legal technology initiatives across prior in-house and private practice roles. He has spearheaded enterprise software procurement, including negotiating vendor engagements and coordinating department rollouts, and served as a lead associate for the pilot and integration of generative AI platforms. Mike actively collaborates with firm innovation teams to develop practical use cases that optimize complex transactional workflows.

    Mike’s practice spans a broad range of corporate transactions, including:

    • Initial public offerings (IPOs) and follow-on offerings
    • Special purpose acquisition company (SPAC) and de-SPAC transactions
    • Cross-border mergers and acquisitions
    • High-yield and investment-grade debt offerings
    • Venture capital and private equity investments

    Prior to joining Latham, Mike served as corporate counsel at NVIDIA and practiced in the corporate groups of two international law firms. Prior to his legal career, Mike worked in investor relations for a global private funds administrator, servicing private equity and hedge fund clients, and in corporate operations for a major telecommunications provider. While in law school, he represented social enterprises and nonprofit organizations as a student attorney in the Social Enterprise and Nonprofit Law Clinic and served as a legal extern in the Whistleblower Office of the Division of Enforcement at the US Commodity Futures Trading Commission.

    Experience

    Mike’s experience includes advising:

    • Xanadu Quantum Technologies on its approximately US$3.1 billion de-SPAC transaction with Crane Harbor Acquisition Corp. and its synthetic at-the-market equity facility for up to US$300 million with Yorkville Advisors*
    • Grindr on its approximately US$2.1 billion de-SPAC transaction with Tiga Acquisition Corp. and strategic corporate matters*
    • Heliogen on its approximately US$2 billion de-SPAC transaction with Athena Technology Acquisition Corp.*
    • IQM Quantum Computers on its approximately US$1.8 billion de-SPAC transaction with Real Asset Acquisition Corp.*
    • DHC Acquisition Corp., a special purpose acquisition company, on its approximately US$358 million de-SPAC transaction with Brand Engagement Network* 
    • Resideo on its US$255 million follow-on public offering*
    • NVIDIA Corporation on several buy-side mergers and acquisitions of technology and artificial intelligence companies, strategic investments, and corporate matters*
    • Cisco on its acquisition of ThousandEyes*
    • Brinker Capital, Inc. on its sale to Genstar Capital and subsequent merger with TA Associates-backed Orion Advisor Solutions*
    • Atlas Holdings on its acquisition of LSC Communications, pursuant to Section 363 of the US Bankruptcy Code*
    • Exela Technologies on its US$160 million accounts receivable securitization facility, its carve-out sale of SourceHOV Tax to Gainline Capital Partners, and strategic corporate matters*
    • Altos Labs in connection with corporate governance and general corporate matters*
    • Andreessen Horowitz (a16z) and Insight Partners in connection with various venture capital and growth equity investments, including in Hinge Health, The Real Brokerage, and Stacker*
    • Bloomberg, Warburg Pincus, and Platinum Equity in connection with various corporate transactions and private equity investments*
    • The underwriters in connection with the US$345.1 million initial public offering of Apogee Therapeutics*
    • The underwriters on the US$234.6 million initial public offering of DICE Therapeutics, Inc.*
    • The underwriters on the US$174.3 million upsized initial public offering of Ventyx Biosciences, Inc.*
    • The underwriters in connection with the US$1.2 billion follow-on public offering of Qualtrics International*
    • The underwriters and initial purchasers in connection with Ascendis Pharma's US$460 million follow-on offering and US$575 million offering of convertible senior notes*
    • The underwriters on the US$345 million convertible senior notes offering of Global Blood Therapeutics, Inc.*

    *Matter handled prior to joining Latham

    Qualifications

    Bar Qualification

    • California
    • New York

    Education

    • JD, Georgetown University Law Center, 2019
    • BS in Psychology, University of Toronto, 2012
      with honors

    Practices

    Industries